A candidate needs the endorsement of 50 lawmakers before the house can vote. The backing of more than half of the lower house's current 492 members - or 247 votes - is required to become prime ...

From healthcare to home loans, education to employment, nearly every veteran benefit starts with one document: Your DD214. Your military discharge papers are officially known as DD Form 214, or just ...

The military's reserve components now issue departing reservists a new standard service record that summarizes their periods of active and inactive service as well as their "points" earned toward ...

NEW YORK -- Iga Swiatek is off to a strong start on her quest to win a second straight major as she beat Emiliana Arango of Colombia 6-1, 6-2 on Tuesday. She marched into Round 2 in exactly one hour, ...

Stay in the clear and keep your finances in order with everything you need to know about IRS Form 941. Many, or all, of the products featured on this page are from our advertising partners who ...

ALLENTOWN, Pa. - The trial of a Lehigh County man accused of killing his girlfriend is set to start soon. Tuesday began with pretrial motions and jury selection at the courthouse in Allentown. Steven ...

SoftBank to become 6th largest Intel shareholder, according to LSEG data SoftBank not seeking board seat or committing to buy Intel chips, says source Intel shares rise ~7%; SoftBank shares close down ...

(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and ...

President Trump has not committed to adding American forces to the mix in Ukraine. No one has detailed publicly what form defenses would take, but there are several options. By David E. Sanger ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Donald Trump won the presidency in part ...

In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...